Substance use during pregnancy has important implications for health care providers and
policymakers and can negatively affect a woman's health and the health of her children. …

Objective To review the use of buprenorphine for opioid-addicted patients in primary care.
Quality of evidence The MEDLINE database was searched for literature on buprenorphine …

Objective: To improve awareness and knowledge of problematic substance use in pregnancy
and to provide evidence-based recommendations for the management of this challenging …

Cannabis is the most commonly used psychoactive substance in Canada. The prevalence of
cannabis use both during pregnancy and in the postpartum period has been estimated at 5…

Objectives To improve awareness and knowledge of problematic substance use in pregnancy
and to provide evidence-based recommendations for the management of this challenging …

Background: Empirical evidence is needed to guide adequate postpartum pain relief of
methadone and buprenorphine stabilized patients. Objectives: To first determine the adequacy of …

… Ordean A , … Wong S, Ordean A, Kahan M, MATERNAL FETAL MEDICINE COMMITTEE,
FAMILY PHYSICIANS ADVISORY COMMITTEE, MEDICO-LEGAL COMMITTEE, AD HOC …

Objective To describe the characteristics of a national cohort of pregnant women on methadone
maintenance treatment (MMT) and to provide treatment outcome data for integrated care …

Objective To assess participant perception of an integrated model of care for substance abuse
in pregnancy. Design Focus groups were employed for this qualitative study. Setting Two …

Ontario’s clinical practice guidelines for neonatal abstinence syndrome (NAS) provide
evidence-informed recommendations that address the needs of substance using pregnant women …